Assessing knowledge, attitudes and belief toward HPV vaccination of parents with children aged 9-14 years in rural communities of Northwest Cameroon: a qualitative study

Lorraine Elit, Calvin Ngalla, Glen Mbah Afugchwi, Eric Tum, Joel Fokom Domgue, Elysée Nouvet, Lorraine Elit, Calvin Ngalla, Glen Mbah Afugchwi, Eric Tum, Joel Fokom Domgue, Elysée Nouvet

Abstract

Background: Human papilloma virus (HPV) vaccination is essential for the WHO cervical cancer elimination initiative. In Cameroon, HPV vaccine uptake is currently 5%. To assess the knowledge, beliefs and attitudes of parents of young girls aged 9-14 years about HPV vaccines within rural communities in the Northwest Region of Cameroon.

Methods: During January-May 2022, we conducted 45 one-on-one interviews using a semistructured interview guide in the localities of Mbingo, Njinikom and Fundong. Participants were parents of girls aged 9-14 years who speak English or Pidgin English. Healthcare workers were excluded. The interviews were recorded, transcribed and analysed using ATLAS.ti V.9. Member checking was conducted presenting our findings and getting feedback from a focus group of parents.

Results: Thirty-five mothers and 10 fathers were interviewed with a mean age of 42 years. Ninety-one per cent of parents had ever been vaccinated. Seventy-seven per cent had no or only primary school education. Thirty-two parents (71.12%) had daughters who had not been vaccinated against HPV. The themes identified include: perceived effectiveness of the HPV vaccine, affective behaviour (how they feel about the vaccine), accessibility (ability to get the vaccine), intervention coherence, ethicality (including parental informed consent), opportunity cost (future potential financial implications of cancer prevention), decision-making in the home (predominantly paternalistic), self-efficacy (extent to which education initiatives were effective) and quality initiatives (use of village infrastructure including fons/qwifons, village crier, healthcare worker presenting at the njangi house, schools and churches). Member checking with 30 women from two other communities confirmed our findings.

Conclusions: Lack of awareness concerning the availability and purpose of the HPV vaccination was prevalent. Use of mainstream media and top-down health education activities are not effective. Novel approaches should engage local community health workers and use established community social and leadership structures.

Trial registration number: ClinicalTrials.gov Registry (NCT05325138).

Keywords: preventive medicine; public health; qualitative research.

Conflict of interest statement

Competing interests: This is an investigator-initiated research project which has been funded by Merck. Merck does not have access to any of the original material but will be provided with any manuscripts that result from this work for review prior to publication.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Lei J, Ploner A, Elfström KM, et al. . HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 2020;383:1340–8. 10.1056/NEJMoa1917338
    1. Path global HPV vaccine introduction overview, 2019. Available: [Accessed Feb 2020].
    1. Lemp JM, De Neve J-W, Bussmann H, et al. . Lifetime prevalence of cervical cancer screening in 55 low- and middle-income countries. JAMA 2020;324:1532–42. 10.1001/jama.2020.16244
    1. HPV Facts . 2021 for Cameroon ICO/IARC information centre on HPV and cancer. Available: [Accessed 14 Feb 2022].
    1. WHO . WHO/ICO information centre on HPV and cervical cancer (HPV information centre). human papillomavirus and related cancers in Cameroon, 2010. Summary report. Available:
    1. Marlow LAV, Waller J, Wardle J. Public awareness that HPV is a risk factor for cervical cancer. Br J Cancer 2007;97:691–4. 10.1038/sj.bjc.6603927
    1. Shelton RC, Snavely AC, De Jesus M, et al. . HPV vaccine decision-making and acceptance: does religion play a role? J Relig Health 2013;52:1120–30. 10.1007/s10943-011-9553-x
    1. LaJoie AS, Kerr JC, Clover RD, et al. . Influencers and preference predictors of HPV vaccine uptake among US male and female young adult college students. Papillomavirus Res 2018;5:114–21. 10.1016/j.pvr.2018.03.007
    1. Mbingo. Available: [Accessed 12 Apr 2022].
    1. Elit L, Ngalla C, Afugchwi GM, et al. . Study protocol for assessing knowledge, attitudes and belief towards HPV vaccination of parents with children aged 9–14 years in rural communities of North West Cameroon: a qualitative study. BMJ Open 2022;12:e062556. 10.1136/bmjopen-2022-062556
    1. Soratto J, Pires DEPde, Friese S. Thematic content analysis using ATLAS.ti software: potentialities for researchs in health. Rev Bras Enferm 2020;73:e20190250. 10.1590/0034-7167-2019-0250
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101. 10.1191/1478088706qp063oa
    1. Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017;17:88. 10.1186/s12913-017-2031-8
    1. Ndonk FT, Schmidt-Ehry B. Sterilizing vaccines in Cameroon. A retrospective survey of rumor. Yaounde: CLE, 2000.
    1. Perlman S, Wamai RG, Bain PA, et al. . Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS One 2014;9:e90912. 10.1371/journal.pone.0090912
    1. Dairo MD, Adeleke MO, Salawu AT, et al. . Parental support for human papilloma virus vaccination by adolescents in Ibadan North local government area, Ibadan, Nigeria. Int J Adolesc Med Health 2016;30:/j/ijamih. 10.1515/ijamh-2016-0034
    1. Ambali RT, John-Akinola YO, Oluwasanu MM. Indepth interviews' on acceptability and concerns for human papilloma virus vaccine uptake among mothers of adolescent girls in community settings in Ibadan, Nigeria. J Cancer Educ 2022;37:748–54. 10.1007/s13187-020-01876-1
    1. Mouallif M, Bowyer HL, Festali S, et al. . Cervical cancer and HPV: awareness and vaccine acceptability among parents in Morocco. Vaccine 2014;32:409–16. 10.1016/j.vaccine.2013.10.069
    1. Francis SA, Katz ML. The HPV vaccine: a comparison of focus groups conducted in South Africa and Ohio Appalachia. Matern Child Health J 2013;17:1222–9. 10.1007/s10995-012-1116-6
    1. Nelson JA, Francis SA, Liverpool J, et al. . Healers in a non-traditional role; a focus group study of Sangoma's knowledge of and attitudes to cervical cancer prevention and screening in Johannesburg, South Africa. Sex Reprod Healthc 2010;1:195–6. 10.1016/j.srhc.2010.07.004
    1. Remes P, Selestine V, Changalucha J, et al. . A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 2012;30:5363–7. 10.1016/j.vaccine.2012.06.025
    1. Katahoire RA, Jitta J, Kivumbi G, et al. . An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health 2008;12:159–72.
    1. Vermandere H, Naanyu V, Mabeya H, et al. . Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya. PLoS One 2014;9:e109353. 10.1371/journal.pone.0109353
    1. Islam JY, Hoyt AM, Ramos S, et al. . Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries. Cancer Causes Control 2018;29:1115–30. 10.1007/s10552-018-1085-1
    1. Vielot NA, Goldberg SK, Zimet G, et al. . Acceptability of multipurpose human papillomavirus vaccines among providers and mothers of adolescent girls: a mixed-methods study in five countries. Papillomavirus Res 2017;3:126–33. 10.1016/j.pvr.2017.04.001
    1. Massey PM, Boansi RK, Gipson JD, et al. . Human papillomavirus (HPV) awareness and vaccine receptivity among Senegalese adolescents. Trop Med Int Health 2017;22:113–21. 10.1111/tmi.12798
    1. Ndiaye M, Sawadogo B, Sonko I, et al. . [Factors associated with scale-up human papillomavirus (HPV) vaccine in Senegal: a case-control survey of parents]. Pan Afr Med J 2021;39:137. 10.11604/pamj.2021.39.137.29229

Source: PubMed

3
S'abonner